Search

Baylor College of Medicine receives $30 million lead gift for bold expansion plans
news › baylor-college-of-medicine-receives-30-million-lead-gift-for-bold-expansion-plans
… Cullen Tower.” To date, gifts to the Cullen Tower total $100 million, more than 65% of Baylor’s $150 million … include $12 million from the DeBakey Medical Foundation, $10 million from the Huffington Foundation and more than $45 … recent commitment to the building brought Baylor to the $100 million milestone of its fundraising goal for the Cullen …
Nautika1: A Multicenter, Phase II, Neoadjuvant And Adjuvant Study Of Multiple Therapies In Biomarker-Selected Patients With Resectable Stages Ib-III Non-Small Cell Lung Cancer (H-52399)
healthcare › clinical-trials › h-52399
… maximal oxygen consumption (VO2 max) should be greater than 10 mL/kg/min. It is acceptable to have the screening PFT … the first dose of study treatment: ANC greater or equal to 1000/uL Platelet count greater or equal to 75,000/uL … Treatment Phase: TKI Cohorts: ANC greater or equal to 1000/uL Platelet count greater or equal to 75,000/uL …
Research Grant Funding
research › ... › grant-funding
… screening and early detection among rural and urban high-risk patients; 2. Maintain and expand a comprehensive … Strategies for Urinary Tract Infections (UTI) in Spanish-Speaking Women … and experiences with prevention and treatment of UTIs, and evaluate the quality-of-life impact of recurrent UTI …
Sexual Health for Women with Disabilities
research › ... › sexual-health
… yourself and your abilities as well as your limitations. 10 For more information, view the Sexual Self-Esteem page . … multiple sclerosis. Multiple Sclerosis Journal. 2014;20:610–616. Kim E. Asexuality in disability narratives. … Canadian Journal of Human Sexuality. 2007;16(3/4):89-100. Rosenberg M. Conceiving the self. New York: Basic …
Device opens doors for expanded use of donor lungs
news › device-for-expanded-use-of-donor-lungs
… these extended criteria for transplant reflect less than 10 percent of transplants in the United States. This trial …
New insight into breast cancer resistance to hormone therapy
news › new-insight-into-breast-cancer-resistance-to-hormone-therapy
… in the clinic.” “Neurofibromin loss is present in at least 10% of metastatic ER+ tumors. As a result of these new data, …
Zhao Wang Lab Research Projects
research › ... › research-projects
… complex on DNA. Mol Cell. 2015 Mar 19;57(6):1047-1058. PubMed Central ID: PMC4369429. Yi P, Wang Z, Feng Q, … multidrug efflux pump AcrAB-TolC. Nat Commun. 2019 Jun 14;10(1):2635. PubMed Central ID: PMC6570770. Chen M, Bell JM, … at subnanometer resolution. Structure. 2022 Jan 6;30(1):107-113.e3. PubMed Central ID: PMC8741639. …
Mustoe Lab Publications
research › ... › publications
… :1708-1723.E10 ( view publication ) C.A. Weidmann, … 107 … : E10244-E10253. ( view publication ) M. Daher¹, … : 10462-75. ( view publication ) A. R. Pah, R. Guimerà, …
A Study of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis (TETON) (H-51478)
healthcare › clinical-trials › h-51478
… Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis (TETON) … : Idiopathic pulmonary fibrosis (IPF) … : The primary objective of the study is to evaluate the safety and efficacy of inhaled … : This is a Phase 3, randomized, double-blind, placebo-controlled, …
Program in Population and Environmental Health Disparities News
academic-centers › ... › news
… at the McGovern Medical School, were awarded more than $10 million over seven years to recruit pregnant women and …